Impact of the UK lockdown on people at risk of COPD

ERJ Open Res. 2021 Nov 22;7(4):00358-2021. doi: 10.1183/23120541.00358-2021. eCollection 2021 Oct.

Authors

Affiliations

¹ National Heart and Lung Institute, Imperial College London, London, UK.
² University Hospital Aintree, University of Liverpool, Liverpool, UK.
³ Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
⁴ Astra-Zeneca, Gothenburg, Sweden.
⁵ Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
⁶ Chiesi, Parma, Italy.
⁷ GSK, Brentford, UK.
⁸ Novartis Pharma AG, Basel, Switzerland.

Abstract

Impact of the UK lockdown on early COPD https://bit.ly/3laMsmi.

Copyright ©The authors 2021.